Updates are available Correction dated 2022-01-21
Click to view Correction: https://doi.org/10.1038/s41589-022-00969-w
-
Authors
Dey, Sourav Kumar http://orcid.org/0000-0002-6546-8937
Filonov, Grigory S.
Olarerin-George, Anthony O.
Jackson, Benjamin T.
Finley, Lydia W. S. http://orcid.org/0000-0003-4023-7574
Jaffrey, Samie R. http://orcid.org/0000-0003-3615-6958
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (F32GM120987)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (T32 CA062948)
Starr Foundation (I12-0051, I12-0051)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R01NS064516, R35NS111631)
American Diabetes Association (1-18-VSN-02)
- License Information
-
More Information
Article History
Received: 20 May 2021
Accepted: 18 October 2021
First Online: 22 December 2021
Change Date: 21 January 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41589-022-00969-w
Competing interests
: S.R.J. is the cofounder of Lucerna Technologies and has equity in this company. Lucerna has licensed technology related to Spinach, Broccoli and other RNA–fluorophore complexes. S.R.J. is a founder of Chimerna Therapeutics and has equity in this company.
